Pharmacia Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221
Summary of Product Characteristics last updated on the eMC: 30/07/2007
SPC Aldactide 25mg and 50mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/07/2007 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 6.1 - List of Excipients
Date of revision of text on the SPC:   04/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


Section 4.5 BANs to INNs changes – indometacin, colestyramine

Section 6.1 Change to INNs for excipient – hydroxypropylmethylcellulose to hypromellose

Updated on 11/07/2006 and displayed until 30/07/2007
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Pending awaiting re-submission
Date of revision of text on the SPC:   08/2005
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Change to section 7 - Marketing Authorisation Holder
Updated on 21/06/2006 and displayed until 11/07/2006
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   08/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Change of MAH from Pharmacia Milton Keynes to Pharmacia Sandwich.
Updated on 01/09/2004 and displayed until 21/06/2006
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
Updated on 31/08/2004 and displayed until 01/09/2004
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
Updated on 26/09/2002 and displayed until 31/08/2004
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MA number
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text

Active Ingredients/Generics

 
   spironolactone
   hydroflumethiazide


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk